Substituted tetracycline compounds
US9012433B2 · kind B2 · utility
0Cited by
79References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2012 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Nov 27, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention pertains to tetracycline compounds of formula (VIIa):R5*, R5*′, R7r*, and R9m* are defined herein. These tetracycline compounds can be used to treat tetracycline compound-responsive states, such as multiple sclerosis and rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.